How to contact us

Office hours and customers service

Pursuant to § 13 para 5 of the General Administrative Procedure Act 1991, the following office hours and customer service are announced for the Federal Office for Safety in Health Care:

Monday until Thursday9.00 - 15.00 h
Friday9.00 - 12.00 h

Notes on enquiries

  • Prior to contacting us, please visit our website for detailed information, as we may have answered your question already.
  • E-mail inquiries should use functional E-mail addresses listed below, so a quick answer is guaranteed even in the case of absences of individual employees.
  • For specific or urgent issues topics and personal contact please use email adressed  with  


AGES MEA is not in charge for following topics:

  • BASG or AGES MEA does not make any individual therapy recommendations. The treatment and the treatment regime is determined by the physician individually for the patient and subject solely the responsibility of the treating physician.
  • Reimbursement of medicines fall within the competence of Hauptverband der österreichischen Sozialversicherungsträger.


 Media Related Contacts

Media enquiries relating activities including press releases, press articles and interviews:

Functional E-Mail Addresses

Active Substance Master File (ASMF, EDMF) 
Analytics -
Analytics - biological (batch releases)
Boderline and classification
BREXIT questions and
Centralised Procedures (Scientific Office)
Certificate of a Pharmaceutical
CESP - technical
Clinical trials on medicinal
Clinical trials on medical devices
Dunning activities, due
DHPC and education
eAF - regulatory
eAF general
Electronic submission (inquiries and technical validation)
ERP European Reference Product inquiries  (AT not RMS)
eServices - technical
Fee and invoice
Free Sales Certificate for medical
GLP Good Laboratory
Innovative medicinal
Inquiries (general)
Inspections of bioequivalence
Inspections of computer-based
Inspections according to
Naming AT=CMS and
National Scientific Advice (NASA)
Non-interventional studies (NIS)
Paediatric worksharing Art 45 and
PDF technical issues
Pharmacovigilance -
Pharmacovigilance -
Pharmacovigilance PHV
Pipeline meeting -
PMF - Plasma Master
Praise or
PSUR and
Quality deficiency
Quality management of the Austrian Medicines and Medical Devices
Reference product
Regulatory, general
Regulatory, product-related
Regulatory, product-related
Regulatory, product-related, national in
Regulatory issues - central
Scientific Advice (ATTENTION! For drug developers only)
Side effects - reporting on human
Sunset clausee-Service-Portal
Veterinary medicines -


BASG - Federal Office for Safety in Health Care

Head of the Office:

Mag. iur. Thomas Reichhart


AGES MEA - Austrian Medicines and Medical Devices Agency

Head of AGES MEA:

Dipl.-Ing. Dr. Christa Wirthumer-Hoche

Traisengasse 5, 1200 Wien


Institutes of AGES MEA:

Institute Marketing Authorisation of Medicinal Products & Lifecycle ManagementMag. Dr. Peter Platzer
Institute Assessment & AnalyticsDr. Gerhard Beck
Institute SurveillanceDipl.-Ing. Dr. Ronald Bauer

Institute Marketing Authorisation of Medicinal Products & Lifecycle Management (LCM)

Head: Mag. Dr. Peter Platzer

Traisengasse 5, 1200 Wien

Regulatory issues

Regulatory, product-related
Regulatory, product-related
Regulatory, product-related, national in

For MRP/DCP, please see also the list of Austrian contact points  at the CMDh website. 

Quality Assessment of Human and Veterinary Medicinal Products (chemical and defined biological Medicinal Products*)

DI Susanne
DI Dr. Wolfgang

* such as Heparins, low molecular Heparins, Insulin, Pancreatin, Menotrophin, Botulinum toxin, Hyaluroidase, enzyme/Lysate of microorganism, Lactobacillus spp., Streptococcus spp., Phospholipids bovine/porcine (see also CMDh Overview of biological active substances of non-recombinant origin)

Quality and Medical assessment of Herbal and Homeopathic Medicinal Productsin Department HEVE

Univ.-Doz. Dr. Reinhard Lä
Dr. Astrid

Medical Assessment of national, MRP and DCP procedures for human medicinal products (except Biologics, Herbals) in Department MRAT

Dr. Ingeborg
Dr. Jascha Hö

Medical Assessment of national, MRP and DCP procedures for veterinary medicinal products  in Department HEVE   

Dr. Gabriele Rothmü
Mag. Ingrid

Institute Assessment & Analytics (BGA)

Head: Dr. Gerhard Beck

Assessment - Traisengasse 5, 1200 Wien

Medical assessment of human medices in Department CASE 

Dr. Barbara
Dr. Jan


Centralised procedures 

Dr. Jan

Biologicals (national, MRP-/DCP-, and centralised procedures)

Dr. Brigitte Mü



Dr. Barbara


Biologicals, Preclinical and Statistical Assessment

Dr. Günter

OMCL Laboratory - Possingergasse 38, 1160 Wien

Analytics biological medicines 

Dipl.-Ing. Heidemarie


OMCL Laboratory - Spargelfeldstraße 191, 1220 Wien

Analytics  chemical-pharmaceutical medicines

Mag. Roman

Institute Surveillance (INS)

Head: Dipl.- Ing. Dr. Ronald Bauer

Traisengasse 5, 1200 Wien


Departments for 

GMP/GDPMag. Andreas Kraßnigg
Clinical trials Dr. Ilona Reischl
Medical Devices Market Surveillance  Dipl.-Ing. Andreas Amon
Blood, Tissue & VigilanceMag. Dr. Verena Plattner

Pharmacovigilance contacts


Single case and signal detection of human medicines

Mag. Katharina
Fax.Nr.:+43 (0)50 555 36207


Pharmacovigilance veterinary medicines

Dr. Anja

Regulatory issues:

Periodic Safety Update Report and Risk Manangement Plan

Dr. Sonja


Pharmacovigilance Implementation / DHCP and Educational Material

Dr. Ulrike
Mag. Rudolf

Availability of all MEA employees

Praise and criticism

For complaints or positive feedbacks to activities of the BASG and AGES MEA or its staff members, please contact us by e-mail

Incoming complaints are checked if they are in the responsibility of the Federal Office for Safety in Health Care (BASG) or the Austrian Medicines and Medical Devices Agency (AGES MEA). You will receive on short notice feedback on the outcome of this check as well as information regarding the actions implemented following justified complaints in our responsibility, as applicable.

Emergency Contact Number +43 (0) 664 831 28 43

Please note: The emergency number should only be used for emergencies according to art. 70 Medical Devices Act or for emergencies within the meaning of art. 10 Pharmacovigilance Regulation. An emergency is considered to be an immediate danger to life or a serious and substantial threat to health.

All other questions can be adressed to other contact points listed here on this page.

24-hour emergency telephone service for pharmacogivilance responsible persons and for safety officers for medical devices.
Tel.: +43 (0) 664 831 28 43


Further inquiry note